Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model

Sjögren’s syndrome (SS) is a systemic autoimmune disease with no efficient treatment, and it is associated with dysregulated immune cells and impaired interleukin (IL)-2 signaling. IL-2 is critical for the development and maintenance of Treg cells. The use of low dose of IL-2 (LDIL-2) in the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yifan, Feng, Ruiling, Cheng, Gong, Huang, Bo, Tian, Jiayi, Gan, Yuzhou, Jin, Yuebo, Miao, Miao, Zhang, Xia, Sun, Xiaolin, He, Jing, Li, Zhanguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160330/
https://www.ncbi.nlm.nih.gov/pubmed/35665339
http://dx.doi.org/10.3389/fmed.2022.887354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160330/
https://www.ncbi.nlm.nih.gov/pubmed/35665339
http://dx.doi.org/10.3389/fmed.2022.887354

Ejemplares similares